Greenlight Capital Re Vs. Neurogene Industry Stock Comparison

Buy

65

GLRE
Greenlight Capital Re

Last Price:

14.60

Seasonality Move:

1.05%

Sell

1

NGNE
Neurogene

Last Price:

19.30

Seasonality Move:

50.43%

Buy

65

Greenlight Capital Re (GLRE) is a Buy

Is Greenlight Capital Re a Buy, Sell or Hold?

The current Greenlight Capital Re [GLRE] share price is $14.50. The Score for GLRE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
GLRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

1

Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

The Greenlight Capital Re share price today is $14.50
The current trend is moderately bullish and GLRE is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $34.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

GLRE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.26	Buy
Relative Strength Index (14 RSI):	57.86	Buy
Chaikin Money Flow:	-6213	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.37 - 14.57)	Buy
Bollinger Bands (100):	(12.89 - 14.11)	Buy

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.55	Sell
Relative Strength Index (14 RSI):	35.74	Sell
Chaikin Money Flow:	-452975	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(41.4 - 61.5)	Sell
Bollinger Bands (100):	(34.32 - 50.52)	Sell

GLRE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	14.72	Sell
20-day SMA:	14.02	Buy
50-day SMA:	13.88	Buy
200-day SMA:	12.95	Buy
8-day EMA:	14.48	Buy
20-day EMA:	14.21	Buy
50-day EMA:	13.89	Buy
200-day EMA:	12.97	Buy

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.3	Sell
20-day SMA:	51.47	Sell
50-day SMA:	46.76	Sell
200-day SMA:	38.99	Sell
8-day EMA:	47.13	Sell
20-day EMA:	50.2	Sell
50-day EMA:	47.47	Sell
200-day EMA:	38.44	Sell

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Greenlight Capital Re Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):